- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Clear All
Trial Details
Key Eligibility Criteria
500 Participants Needed
Trial Details
Key Eligibility Criteria
2012 Participants Needed
Trial Details
Key Eligibility Criteria
1020 Participants Needed
Trial Details
Key Eligibility Criteria
624 Participants Needed
Trial Details
Key Eligibility Criteria
1514 Participants Needed
Trial Details
Key Eligibility Criteria
782 Participants Needed
Trial Details
Key Eligibility Criteria
129 Participants Needed
Trial Details
Key Eligibility Criteria
10273 Participants Needed
Trial Details
Key Eligibility Criteria
1180 Participants Needed
Trial Details
Key Eligibility Criteria
386 Participants Needed
Trial Details
Key Eligibility Criteria
1636 Participants Needed
Trial Details
Key Eligibility Criteria
1200 Participants Needed
Trial Details
Key Eligibility Criteria
2400 Participants Needed
Trial Details
Key Eligibility Criteria
3960 Participants Needed
Trial Details
Key Eligibility Criteria
1295 Participants Needed
Trial Details
Key Eligibility Criteria
1300 Participants Needed
Trial Details
Key Eligibility Criteria
1670 Participants Needed
Trial Details
Key Eligibility Criteria
1031 Participants Needed
Trial Details
Key Eligibility Criteria
466 Participants Needed
Trial Details
Key Eligibility Criteria
190 Participants Needed
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've had radiation and as far as I know I’m in remission, but my brother passed away with the same condition. I don’t mind helping research for a cure... my husband passed away with pancreatic cancer. I've had a stepdaughter that passed away with ovarian cancer at 20. I just think it’s time to knock cancer out! I'd really like to help find better treatments by participating in a trial."
"I had two chemotherapy regímens without success, three surgeries during which the tumor could not be resected. These clinical trials are a light of hope for me and my family (I have a five year old child) and I have read about cases of success in other types of cancer with this treatment. I think that I am a perfect candidate for this tríal. Thank you."
"I've tried chemotherapy and radiation but the cancer recurred. My oncologist suggested that I might want to try a clinical trial given my situation. Just starting to research, hoping to learn more."
"My mom has cholangiocarcinoma with bone mts (FGFR2 mutation). She really needs this trial to survive. She’s active and her analysis is ok, but we have very limited other options. Hope to work with a high-quality clinic to prolong her quality and duration of life."
Trial Details
Key Eligibility Criteria
1728 Participants Needed
Trial Details
Key Eligibility Criteria
5500 Participants Needed
Trial Details
Key Eligibility Criteria
8000 Participants Needed
Trial Details
Key Eligibility Criteria
320 Participants Needed
Trial Details
Key Eligibility Criteria
650 Participants Needed
Trial Details
Key Eligibility Criteria
250 Participants Needed
Trial Details
Key Eligibility Criteria
557 Participants Needed
Trial Details
Key Eligibility Criteria
5101 Participants Needed
Trial Details
Key Eligibility Criteria
5637 Participants Needed
Trial Details
Key Eligibility Criteria
1155 Participants Needed
Know someone looking for new options?
Spread the word